
Sign up to save your podcasts
Or
In India, a group of researchers raced to develop a CRISPR-based genome editing therapy to save the life of a young woman with a rare neurodegenerative disease. Despite a valiant effort, the pace of research was ultimately too slow to save her life. While many are convinced that these therapies could offer hope to those with overlooked genetic conditions, it will likely take years to develop the techniques needed to quickly create bespoke treatments, something people in need don't have.
This is an audio version of our Feature: Hope, despair and CRISPR — the race to save one woman’s life
Hosted on Acast. See acast.com/privacy for more information.
4.5
701701 ratings
In India, a group of researchers raced to develop a CRISPR-based genome editing therapy to save the life of a young woman with a rare neurodegenerative disease. Despite a valiant effort, the pace of research was ultimately too slow to save her life. While many are convinced that these therapies could offer hope to those with overlooked genetic conditions, it will likely take years to develop the techniques needed to quickly create bespoke treatments, something people in need don't have.
This is an audio version of our Feature: Hope, despair and CRISPR — the race to save one woman’s life
Hosted on Acast. See acast.com/privacy for more information.
6,090 Listeners
935 Listeners
592 Listeners
806 Listeners
608 Listeners
414 Listeners
1,367 Listeners
109 Listeners
343 Listeners
953 Listeners
0 Listeners
16 Listeners
4 Listeners
353 Listeners
396 Listeners
478 Listeners
472 Listeners
114 Listeners